Clinical Trial Update: Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating how growth hormone, peptide YY, and pancreatic polypeptide affect ghrelin in bulimia nervosa, currently enrolling by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bulimia Nervosa
• Eating Disorders

Drugs mentioned

• Pancreatic polypeptide (pancreatic polypeptide)
• Peptide YY (peptide YY)
• Somatropin (somatropin)

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Eating Disorder, Bulimia Nervosa | Phase 2 | Status: ENROLLING_BY_INVITATION